2025-07-16 - Analysis Report
Okay, here's an analysis of Eli Lilly and Co (LLY) based on the provided data, presented in an easy-to-understand format.

**Report on Eli Lilly and Co (LLY)**

**Company Overview:** Eli Lilly and Co is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (LLY):** 247.33%
*   **Cumulative Return (VOO):** 95.00%
*   **Absolute Divergence:** 152.33% (LLY significantly outperformed VOO)
*   **Relative Divergence:** 55.7 (LLY's outperformance is in the upper half of its historical range compared to VOO)

**Analysis:** LLY has substantially outperformed the S&P 500. The relative divergence suggests that this outperformance is significant compared to its historical trend.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta  | Cap(B) |
| :----------- | :------ | :------ | :----- | :---- | :----- |
| 2015-2017  | 10.0%   | 56.3%   | -19.0% | 0.0   | 75.8   |
| 2016-2018  | 39.0%   | 58.6%   | 21.0%  | -0.1  | 103.9  |
| 2017-2019  | 50.0%   | 58.6%   | 20.0%  | 0.3   | 118.0  |
| 2018-2020  | 52.0%   | 58.6%   | 33.0%  | 0.1   | 151.6  |
| 2019-2021  | 106.0%  | 60.6%   | 57.0%  | 0.2   | 248.0  |
| 2020-2022  | 98.0%   | 64.8%   | 96.0%  | 0.2   | 328.4  |
| 2021-2023  | 133.0%  | 64.8%   | 115.0% | 0.3   | 523.3  |
| 2022-2024  | 150.0%  | 72.2%   | 124.0% | 0.2   | 693.0  |
| 2023-2025  | 100.0%  | 76.8%   | 53.0%  | 0.2   | 692.8  |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  CAGR 수치가 전반적으로 높은 수준이며, 특히 최근 기간에 급격하게 상승했습니다. 이는 LLY의 높은 성장세를 보여줍니다.

*   **MDD (Maximum Drawdown):**  MDD는 투자 기간 동안의 최대 손실을 나타내는데, 56.3% ~ 76.8% 사이로 상당히 높은 편입니다. 이는 투자에 따른 위험도 크다는 것을 의미합니다.

*   **Alpha:** Alpha는 시장 대비 초과 수익률을 나타내는데, 모든 기간에서 양수 값을 보이며, 특히 최근 기간에 매우 높은 수치를 기록하고 있습니다. 이는 LLY가 시장 평균보다 훨씬 높은 수익을 올리고 있음을 시사합니다.

*   **Beta:** Beta는 시장 변동성에 대한 민감도를 나타냅니다. 0.0 ~ 0.3 사이의 값을 가지며, 이는 LLY가 시장 변동성에 크게 영향을 받지 않는 안정적인 주식임을 나타냅니다.

*   **Cap(B) (Market Capitalization):** 시가총액은 꾸준히 증가하여 692.8B까지 도달했습니다. 이는 회사의 규모가 지속적으로 성장하고 있음을 보여줍니다.

*   종합적으로 LLY는 높은 성장률과 시장 대비 높은 초과 수익률을 보이지만, 최대 손실폭도 큰 편이므로 투자 시 위험 관리가 필요합니다.

**2. Recent Price Action**

*   **Current Price:** \$771.75
*   **Previous Close:** \$799.34
*   **Change:** -3.45% (recent price drop)
*   **5-day Moving Average:** \$788.33
*   **20-day Moving Average:** \$783.41
*   **60-day Moving Average:** \$782.58

**Analysis:** The current price is below all three moving averages, indicating a short-term downtrend. The recent price drop of -3.45% suggests some negative pressure.

**3. Market Risk Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.341 (Low Risk)
*   **RSI:** 47.20 (Neutral)
*   **PPO:** -0.0409 (Negative momentum)
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence (20-day):** 1.8 (+, Short-term Increase)
*   **Expected Return:** 130.6% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI indicates a low-risk environment.
*   The RSI is neutral, suggesting neither overbought nor oversold conditions.
*   The PPO indicates negative momentum.
*   The Hybrid Signal suggests a cautious buying approach, even though the MRI is low.
*   The positive change in relative divergence suggests a recent improvement in performance relative to the S&P 500.
*   The high expected return suggests strong long-term growth potential compared to the S&P 500.
*   The price drop is significant and requires further investigation.

**4. Recent News & Significant Events**

*   **[2025-07-15]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-12]:** Analyst discussion of recent performance and outlook.
*   **[2025-07-13]:** Notable stock volatility.
*   **[2025-07-14]:** Market experts highlighting risks and opportunities.

**Analysis:** The news suggests recent activity and volatility surrounding LLY. These events warrant further investigation to understand their impact on the company.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출         |
| :--------- | :--- | :----------- |
| 2025-05-01 | 3.07 | 12.73 B$     |
| 2024-10-30 | 1.08 | 11.44 B$     |
| 2024-08-08 | 3.29 | 11.30 B$     |
| 2024-04-30 | 2.49 | 8.77 B$      |
| 2025-05-01 | 2.49 | 8.77 B$      |

**Analysis:**

*   The Earnings per Share (EPS) and Revenue have been showing an upward trend generally.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
| :----------- | :-------- | :------------ |
| 2025-03-31 | \$12.73B | 82.53%        |
| 2024-12-31 | \$13.53B | 82.24%        |
| 2024-09-30 | \$11.44B | 81.02%        |
| 2024-06-30 | \$11.30B | 80.80%        |
| 2024-03-31 | \$8.77B  | 80.91%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
| :----------- | :-------- | :------- |
| 2025-03-31 | \$15.76B | 17.50%   |
| 2024-12-31 | \$14.19B | 31.07%   |
| 2024-09-30 | \$14.24B | 6.81%    |
| 2024-06-30 | \$13.56B | 21.88%   |
| 2024-03-31 | \$12.81B | 17.51%   |

**Analysis:**

*   **Revenue:** Revenue has generally been increasing, indicating strong sales performance.
*   **Profit Margin:** The profit margin is consistently high, indicating efficient operations and strong pricing power.
*   **Equity:** Equity is growing, suggesting healthy capital accumulation.
*   **ROE (Return on Equity):** ROE is volatile, but generally strong, indicating good profitability relative to equity.

**7. Overall Summary**

*   **Strong Outperformance:** LLY has significantly outperformed the S&P 500, with substantial cumulative and relative divergence.
*   **Recent Price Weakness:** There is a recent price drop and short-term downtrend.
*   **Positive Long-Term Outlook:** Despite the short-term weakness, the expected return remains high, indicating strong long-term growth potential.
*   **Key Considerations:** Recent news suggests potential volatility and significant events that could impact the stock. The high MDD also indicates a high-risk investment.
*   **Earnings & Financials:** Recent earnings show positive trends in EPS and revenue. Strong profit margins and healthy equity growth further support the company's financial health.

**Conclusion:**

LLY presents a mixed picture. While it has a history of strong outperformance and a positive long-term outlook, recent price weakness and potential volatility require careful consideration. Investors should monitor the news, earnings, and financial data closely and consider their risk tolerance before investing.
